Hospital Length of Stay

Switching to oral step-down therapy after clinical response shortened hospital length of stay. EAA inhibitors were not associated with a statistically significant difference in ICU length of stay. EAA inhibitor use was associated with a statistically significant reduction in hospital length of stay. UOGCSH hospital stays were longer than those reported in previous studies. ICU and hospital length of stay were secondary outcomes in the review. Arithmetic mean length of stay is unreliable for benchmarking because LOS data are skewed and affected by patient case-mix. Average hospital length of stay was about 13.46 days. More than half of participants stayed in hospital longer than 14 days. The certainty of evidence for length-of-stay outcomes was low. Average LOS can make hospitals treating more complex patients appear inefficient. Repeated or subsequent source control procedures were associated with longer hospital stays. Average LOS remains useful for describing resource consumption but is misleading as a performance comparator. Hospital length of stay is used as an indicator of hospital efficiency and care quality.